We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sequenom Sued by Beckman Coulter and Orchid Cellmark

By Labmedica staff writers
Posted on 30 Jun 2008
Beckman Coulter (Fullerton, CA, USA) and Orchid Cellmark (Dayton, OH, USA) have filed a lawsuit against Sequenom (San Diego, CA, USA) in a patent infringement case that alleges Sequenom is guilty of violating patents belonging to Orchid and licensed to Beckman.

Sequenom is being sued over its MassArray iPlex products that are designed for single nucleotide polymorphism (SNP) genotyping applications. More...
Beckman Coulter and Orchid Cellmark claim that the products infringe on three patents that cover techniques and reagents used for genotyping applications, part of Beckman's GenomeLab SNPstream genotyping system--an automated scaling system capable of performing 4,600-3,000,000 SNP genotypes per day.

The three patents in dispute refer to a reagent composition that can determine the identity of a nucleotide base at a specific position in a nucleic acid of interest. The invention may be used to determine the presence or absence of a specific nucleotide sequence in a sample. It may also be employed in determination of genotype and in the identification of different alleles.

Sequenom said in a filing with the U.S. Securities and Exchange Commission in June 2008 that it believed that the plaintiffs' claims were without merit and it would vigorously defend against the claims advanced in the complaint.

The firms have asked the court to permanently instruct Sequenom to refrain from selling products that they believe infringe the three patents. In addition, the companies are also seeking damages for lost profit and costs associated with the lawsuit.


Related Links:
Beckman Coulter
Orchid Cellmark
Sequenom

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.